SLC7A11 and Alzheimer disease: Our results showed that compared with those of non-AD patients, the aortas of TAAD patients exhibited downregulated protein levels of SLC7A11, FSP1 and GPX4 (Figure 1D-1G and Supplemental Figure S2).